Thomas F. Tedder

Fundador en Cellective BioTherapy, Inc. .

Health Technology

Perfil

Thomas F.
Tedder is associated with two companies, Cellective Therapeutics, Inc. and Cellective BioTherapy, Inc. He was the Chief Scientific Officer at Cellective Therapeutics, Inc. from 2003 to 2008.
He is currently the Chief Executive Officer and Director at Cellective BioTherapy, Inc., which he founded in 2015.

Cargos activos de Thomas F. Tedder

Empresas	Cargo	Inicio
Cellective BioTherapy, Inc. Cellective BioTherapy, Inc. Pharmaceuticals: MajorHealth Technology Cellective BioTherapy, Inc. engages in the research and development of novel cellular and monoclonal antibody-based platforms for treating cancers, autoimmunity, and immunodeficiency. Its proprietary pipeline and technology platform focuses on the unique aspects of B cell biology that are involved in regulating a variety of autoimmune diseases and inflammatory immune responses. The company was founded by Thomas F. Tedder in 2015 and is headquartered in Durham, NC.	Fundador	01/01/2015

Todos los cargos activos de Thomas F. Tedder

Antiguos cargos conocidos de Thomas F. Tedder.

Empresas	Cargo	Fin
Cellective Therapeutics, Inc. Cellective Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Cellective Therapeutics, Inc. provides biopharmaceuticals products. It develops monoclonal antibodies for the treatment of oncology and autoimmune diseases. Cellective Therapeutics products include monoclonal antibodies that target the B-cell antigens CD19, CD20 and CD22 are in preclinical stage programs. It was founded by Thomas F. Tedder and Alter E. Geller in May, 2003 and is headquartered in Durham, NC	Fundador	14/11/2008

Ver el detalle de la experiencia de Thomas F. Tedder.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Thomas F. Tedder.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
Cellective Therapeutics, Inc. Cellective Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Cellective Therapeutics, Inc. provides biopharmaceuticals products. It develops monoclonal antibodies for the treatment of oncology and autoimmune diseases. Cellective Therapeutics products include monoclonal antibodies that target the B-cell antigens CD19, CD20 and CD22 are in preclinical stage programs. It was founded by Thomas F. Tedder and Alter E. Geller in May, 2003 and is headquartered in Durham, NC	Health Technology
Cellective BioTherapy, Inc. Cellective BioTherapy, Inc. Pharmaceuticals: MajorHealth Technology Cellective BioTherapy, Inc. engages in the research and development of novel cellular and monoclonal antibody-based platforms for treating cancers, autoimmunity, and immunodeficiency. Its proprietary pipeline and technology platform focuses on the unique aspects of B cell biology that are involved in regulating a variety of autoimmune diseases and inflammatory immune responses. The company was founded by Thomas F. Tedder in 2015 and is headquartered in Durham, NC.	Health Technology